DNA X Inc. filed an amended Form 8-K/A to correct its prior December 18, 2025 Form 8-K disclosure about its Dec. 15, 2025 acquisition of DNA X LLC. The company said it determined the transaction did not involve a “significant amount of assets” under Item 2.01, and therefore it will not provide the financial statements or pro forma information referenced in the original report.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DNA X Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-008444), on March 02, 2026, and is solely responsible for the information contained therein.
Comments